Company Filing History:
3 out of 169 
2 out of 344 
2 out of 894 
Years Active: 2013-2021
Title: Chamutal Gur: Innovator in Medical Research
Introduction
Chamutal Gur is a prominent inventor based in Jerusalem, Israel. He has made significant contributions to the field of medical research, particularly in the areas of cancer treatment and diabetes management. With a total of 3 patents, Gur's work reflects his commitment to advancing healthcare solutions.
Latest Patents
One of Gur's latest patents is focused on attenuated or inactivated pathogenic bacteria for treating urogenital cancer. This invention provides innovative compositions comprising these bacteria, which possess anti-cancer properties, aimed at treating cancers of the urogenital system. Another notable patent involves a method for treating type 1 diabetes by administering NKp46 polypeptide. This invention utilizes the natural cytotoxicity receptor NKp46 to prevent and treat diabetes, including both type 1 and type 2 diabetes. The compositions developed in this patent aim to prevent the onset and progression of diabetes.
Career Highlights
Chamutal Gur has worked with esteemed organizations such as Hadasit Medical Research Services and Development Ltd. and Ben-Gurion University of the Negev Research and Development Authority. His experience in these institutions has allowed him to collaborate on groundbreaking research projects that have the potential to impact patient care significantly.
Collaborations
Gur has collaborated with notable colleagues, including Ofer Mandelboim and Angel Porgador. These partnerships have fostered an environment of innovation and have contributed to the success of his research endeavors.
Conclusion
Chamutal Gur's contributions to medical research through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in the treatment of cancer and diabetes, showcasing the importance of innovation in healthcare.